Next report date
—
Report period
—
EPS estimate
—
Revenue estimate
—
−0.72EUR
−8.84 MEUR
583.60 KEUR
4.09 M
About 4BASEBIO PLC ORD EUR1
Sector
Industry
CEO
Heikki Lanckriet
Website
Headquarters
Cambridge
Founded
2020
ISIN
GB00BMCLYF79
FIGI
BBG00Z5HKCG3
4basebio Plc is a biotechnology company, which engages in the business of developing advanced therapy medicinal products through synthetic DNA products and non-viral, cell targeting nucleic acid delivery platforms. The firm is involved in manufacturing and supplying high quality synthetic DNA products for research, therapeutic, and pharmacological use; and developing target specific non-viral vectors for the efficient delivery of payloads in patients. The company was founded on December 22, 2020 and is headquartered in Cambridge, the United Kingdom.
Trade directly on the supercharts through our supported, fully-verified and user-reviewed brokers.
Frequently Asked Questions
The current price of 88Q is 17.00 EUR — it has decreased by 3.41% in the past 24 hours. Watch 4BASEBIO PLC stock price performance more closely on the chart.
Depending on the exchange, the stock ticker may vary. For instance, on GETTEX exchange 4BASEBIO PLC stocks are traded under the ticker 88Q.
88Q stock has fallen by 5.56% compared to the previous week, the last month showed zero change in price, over the last year 4BASEBIO PLC has showed a 174.19% increase.
We've gathered analysts' opinions on 4BASEBIO PLC future price: according to them, 88Q price has a max estimate of 21.13 EUR and a min estimate of 21.13 EUR. Watch 88Q chart and read a more detailed 4BASEBIO PLC stock forecast: see what analysts think of 4BASEBIO PLC and suggest that you do with its stocks.
88Q stock is 3.53% volatile and has beta coefficient of 0.32. Track 4BASEBIO PLC stock price on the chart and check out the list of the most volatile stocks — is 4BASEBIO PLC there?
Today 4BASEBIO PLC has the market capitalization of 232.86 M, it has decreased by 14.92% over the last week.
Yes, you can track 4BASEBIO PLC financials in yearly and quarterly reports right on TradingView.
4BASEBIO PLC is going to release the next earnings report on Sep 27, 2024. Keep track of upcoming events with our Earnings Calendar.
88Q net income for the last half-year is −4.74 M EUR, while the previous report showed −4.14 M EUR of net income which accounts for −14.58% change. Track more 4BASEBIO PLC financial stats to get the full picture.
No, 88Q doesn't pay any dividends to its shareholders. But don't worry, we've prepared a list of high-dividend stocks for you.
EBITDA measures a company's operating performance, its growth signifies an improvement in the efficiency of a company. 4BASEBIO PLC EBITDA is −7.32 M EUR, and current EBITDA margin is −1.25 K%. See more stats in 4BASEBIO PLC financial statements.
Like other stocks, 88Q shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade 4BASEBIO PLC stock right from TradingView charts — choose your broker and connect to your account.
Investing in stocks requires a comprehensive research: you should carefully study all the available data, e.g. company's financials, related news, and its technical analysis. So 4BASEBIO PLC technincal analysis shows the sell today, and its 1 week rating is buy. Since market conditions are prone to changes, it's worth looking a bit further into the future — according to the 1 month rating 4BASEBIO PLC stock shows the buy signal. See more of 4BASEBIO PLC technicals for a more comprehensive analysis.
If you're still not sure, try looking for inspiration in our curated watchlists.
If you're still not sure, try looking for inspiration in our curated watchlists.